The physician ordered 2/3 strength Ensure 6 oz PO q4h for 24 hrs. What is the total volume in mL you would administer in 24 hrs?

A) Antibiotics
Antibiotics are medications used to treat infections by killing or inhibiting the growth of bacteria. They do not have any direct effect on clot formation. Antibiotics work by targeting specific parts of bacterial cells, such as cell walls, proteins, or DNA, but they do not interfere with the blood coagulation system. Therefore, antibiotics are not a drug group that inhibits clot formation.

B) Analgesics
Analgesics are pain-relieving medications used to reduce pain, and they include both non-opioid (e.g., acetaminophen, NSAIDs) and opioid medications (e.g., morphine, oxycodone). While some analgesics, particularly nonsteroidal anti-inflammatory drugs (NSAIDs), can affect platelet function and may slightly influence clotting, their primary function is to relieve pain.

C) Antidepressants
Antidepressants are medications used to treat mood disorders, including depression, anxiety, and other psychiatric conditions. These drugs work by altering the balance of neurotransmitters in the brain, such as serotonin, norepinephrine, or dopamine. Antidepressants do not directly affect blood clotting mechanisms, although some classes, such as selective serotonin reuptake inhibitors (SSRIs), can have mild anticoagulant effects due to their impact on platelet aggregation.

D) Anticoagulants
Anticoagulants inhibit the coagulation cascade, a series of complex biochemical reactions that lead to the formation of a blood clot. Common examples of anticoagulants include warfarin, heparin, and the newer direct oral anticoagulants (DOACs) such as rivaroxaban and apixaban. Anticoagulants are primarily used to reduce the risk of clot formation in conditions such as deep vein thrombosis (DVT), pulmonary embolism (PE), and atrial fibrillation (AF), and they are essential in managing and preventing clot-related complications.

A) Esophagus
Enteric-coated tablets are designed to not dissolve or disintegrate in the esophagus. They are coated with a protective layer that prevents the tablet from breaking down in the acidic environment of the stomach. This is to ensure that the medication is released in the part of the digestive tract where it is most needed, typically beyond the stomach.

B) Duodenum
Enteric-coated tablets are designed to disintegrate in the duodenum, which is the first part of the small intestine. The coating protects the tablet from stomach acid, allowing it to pass intact through the stomach and into the small intestine, where the pH is higher and the coating dissolves, releasing the medication for absorption.

C) Stomach
Enteric-coated tablets are specifically designed not to disintegrate in the stomach because the stomach's acidic environment could either damage the drug or cause premature release. The coating ensures that the drug is protected until it reaches the more neutral pH of the duodenum.

D) Colon
The colon is too far along in the digestive tract for enteric-coated tablets to typically disintegrate. The design of enteric coatings is intended to protect the drug until it reaches the duodenum, where absorption is most efficient. Enteric coatings are not meant to disintegrate in the colon.